Andrew Oxtoby

All filings by Andrew Oxtoby on record concern Aimmune Therapeutics, Inc. In total, 9 filings cover trades dated from 22 January 2019 to 13 October 2020.

The open-market record is one-sided, with 1 purchase worth €40k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants. So far in 2020, the count stands at 1 purchase and no sales.

On 14 October 2020 came the latest disclosure, a transaction for €186k in Aimmune Therapeutics, Inc. The last insider purchase was made public on 17 March 2020, 2,411 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.